First human trial of Oxford Covid-19 vaccine shows promise

London - An experimental coronavirus vaccine being developed by AstraZeneca and Oxford university was safe and produced an immune response in early-stage clinical trials, data showed on Monday, keeping alive the hope it could be in use by the end of the year.

More than 150 possible vaccines are in various stages of development with U.S. drugmaker Pfizer and China's CanSino Biologics also reporting positive responses for their candidates on Monday. UK Prime Minister Boris Johnson, whose government has helped to fund the project, hailed the results as "very positive news.""There is still much work to be done before we can confirm if our vaccine will help manage the Covid-19 pandemic," vaccine developer Sarah Gilbert said.

AstraZeneca shares surged 10%, but then gave up most of those gains, to trade 1.2% stronger on the day.

Education Education Latest News, Education Education Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Coronavirus: Oxford-AstraZeneca Covid vaccine study shows dual immune actionA coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen.
Source: dailymaverick - 🏆 3. / 84 Read more »